NEURONETICS INC (STIM)
US64131A1051 - Common Stock
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
Lack of early symptom improvement is not predictive of final responder status
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
Lack of early symptom improvement is not predictive of final responder status...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
NeuroStar is the first and only TMS therapy cleared as an adjunct treatment for patients ages 15 and older
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
NeuroStar is the first and only TMS therapy cleared as an adjunct treatment for patients ages 15 and older...
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
MALVERN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and...
Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
MALVERN, Pa., March 05, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology...
Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call
MALVERN, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that it plans to release fourth quarter 2023 financial and operating results prior to market open on Tuesday, March 5th, 2024. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day.
Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System
Advancements provide workflow efficiencies for NeuroStar® TMS providers
Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System
Advancements provide workflow efficiencies for NeuroStar® TMS providers...
NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
Criteria Change Reduces Requirements for Treatment Accessibility
NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
Criteria Change Reduces Requirements for Treatment Accessibility...
Neuronetics expects preliminary Q4 revenue to be over $20M (NASDAQ:STIM)
Neuronetics reports preliminary Q4 2023 revenue of over $20 million, exceeding guidance, with positive cash flow and strong year-end financials.
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results
MALVERN, Pa., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology...
Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory
New accessory for NeuroStar TMS reduces patient setup steps and improves efficiency for providers
Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory
New accessory for NeuroStar TMS reduces patient setup steps and improves efficiency for providers...
NeuroStar TMS receives expanded regulatory approval in Japan (NASDAQ:STIM)
Neuronetics secures regulatory approval for its NeuroStar TMS Therapy System in Japan, enhancing the treatment experience for major depressive disorder...
NeuroStar TMS Receives Expanded Regulatory Approval in Japan
Technological advances reduce time and increase efficiency for MDD treatment
NeuroStar TMS Receives Expanded Regulatory Approval in Japan
Technological advances reduce time and increase efficiency for MDD treatment...
Neuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference
MALVERN, Pa., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and...
NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
New updates designed to advance practice efficiency and patient outcomes
NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
New updates designed to advance practice efficiency and patient outcomes...
Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
Policy Updates from Magellan and Two Additional Payors Increase Access for 3.2 Million Covered Lives
Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
Policy Updates from Magellan and Two Additional Payors Increase Access for 3.2 Million Covered Lives...
Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call
MALVERN, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...
Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes
Findings confirm strong correlation between the number of TMS treatment sessions completed and improvement in MDD
Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes
Findings confirm strong correlation between the number of TMS treatment sessions completed and improvement in MDD...
Neuronetics Draws Down Remaining $22.5 Million Available Under Credit Facility
MALVERN, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision...
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
Portal provides resources to raise awareness around mental health and suicide prevention
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
Portal provides resources to raise awareness around mental health and suicide prevention...